Fig. 4From: Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivoExperimental design and dosing paradigm of the chronic in vivo MLi-2 proteomics experiment. a Schematic of experimental design for the chronic MLi-2 proteomics experiment. b 10-Day cohort animals observed no weight changes (male and female body weight trends are shown separated within genotypes as square and circle points, respectively) and consumed ~ 4 g of chow per day c. Daily dose of MLi-2 was calculated by body weight and food intake and showed that animals on average received ~ 65 mg/kg/day of drug d. e 10-Week cohort animals grew 3-8 g in body weight over the course of 10 weeks (shown as % weight change), with an average food intake of 4 g f and hit the 60 mg/kg/day mark each week gBack to article page